GVS TM, Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1630 W Industrial Park Street, Covina, California (CA) 91722, United States (USA)
- Operations here
- labelmanufacture
- FDA identifiers
- FEI 2013342 · DUNS 119067149
Recent inspection flagged official action
FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 3 drugs. A supply problem here can ripple to all of them.
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIBlood and Blood Products2026-05-01
- NAIBlood and Blood Products2023-09-22
- VAIDrug Quality Assurance2019-09-25
- VAIDrug Quality Assurance2018-05-15
- NAIDrug Quality Assurance2014-08-19
- VAIDrug Quality Assurance2012-11-08
- NAIDrug Quality Assurance2011-03-18
- NAIBlood and Blood Products2010-06-25
- VAIDrug Quality Assurance2010-06-25
Drugs this plant is listed as making
3 distinct drugs across 3 products name this site in their FDA label.
- As-3Gvs Tm Inc
- Cp2dGvs Tm Inc
- Sterile Cord Blood Collection UnitGlobal Life Sciences Solutions USA LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.